Journal Article

Compare and contrast: pediatric cancer versus adult malignancies

Mike-Andrew, Westhoff, Karpel-Massler Georg, Klaus-Michael, Debatin, Bartholomae, Stephan, Grunert, Michael, Strobel, Hannah, Peraud Aurelia, Fitzel Rahel, Kattner, Patricia, Pruss Maximilian, Siegelin, Markus D, Khoshnevis Nika, Marc-Eric, Halatsch, Schilberg Katharina

2019

Overview

Cancer is a leading cause of death in both adults and children, but in terms of absolute numbers, pediatric cancer is a relatively rare disease. The rarity of pediatric cancer is consistent with our current understanding of how adult malignancies form, emphasizing the view of cancer as a genetic disease caused by the accumulation and selection of unrepaired mutations over time. However, considering those children who develop cancer merely as stochastically “unlucky” does not fully explain the underlying aetiology, which is distinct from that observed in adults. Here, we discuss the differences in cancer genetics, distribution, and microenvironment between adult and pediatric cancers and argue that pediatric tumours need to be seen as a distinct subset with their own distinct therapeutic challenges. While in adults, the benefit of any treatment should outweigh mostly short-term complications, potential long-term effects have a much stronger impact in children. In addition, clinical trials must cope with low participant numbers when evaluating novel treatment strategies, which need to address the specific requirements of children.

• Publisher: Springer Nature B.V
• Subject: Adults / Cancer / Children / Clinical trials / Long-term effects / Pediatrics / Rare diseases / Tumors